The agreement ensures sustainable access to this innovative therapy for eligible patients ages 12 years and older in Germany-BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) ...
Lupron Depot (leuprolide acetate) is a brand-name injection prescribed for prostate cancer and other hormone-related conditions. Lupron Depot’s side effects may vary depending on the dosage and the ...
ZUSDURI™ generated revenue of $29.2 million in Q1 2026, representing 109% quarter-over-quarter growth, reflecting broader utilization with the ...
The agreement ensures sustainable access to this innovative therapy for eligible patients ages 12 years and older in Germany- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today ...
Red-light therapy promises to treat everything from acne and hair loss to depression and chronic pain. Many of these claims ...
Racism that fueled the syphilis study still permeates the U.S. health care system, causing disparities in access to medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results